In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Immunohematology Analyzers and Reagents
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Immunohematology Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the ... Read More
-
Microfluidics
... 16.0% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth in ... Read More
-
Multiplex Assays
... CAGR of 6.4% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion by the end of the analysis period. ... Read More
-
Oxidative Stress Assays
... at a CAGR of 8.4% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.3 Billion by the end of the ... Read More
-
Mice Model
... CAGR of 5.3% over the analysis period 2024-2030. CRISPR / CAS9, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$976.7 Million by the end of the ... Read More
-
Nucleic Acid Isolation and Purification
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.3 Billion by ... Read More
-
Paper Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end ... Read More
-
Point-of-Care/Rapid Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Other POC Products, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
-
Platelet Aggregation Devices
... at a CAGR of 5.0% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$465.4 Million by the end of the ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
-
Pregnancy Detection Kits
... at a CAGR of 4.8% over the analysis period 2024-2030. Home Pregnancy Tests (HPT), one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$805.2 Million by the ... Read More
-
Rapid Tests
... CAGR of 5.9% over the analysis period 2024-2030. PCR-based, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$20.0 Billion by the end of the analysis period. ... Read More
-
Specimen Validity Testing
... at a CAGR of 5.0% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Therapeutic Plasma Exchange
... at a CAGR of 6.2% over the analysis period 2024-2030. Neurological Disorders, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million by the end of ... Read More
-
Plasma Therapy
... CAGR of 7.4% over the analysis period 2024-2030. Pure PRP, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$468.4 Million by the end of the analysis ... Read More
-
Poultry Diagnostics
... CAGR of 9.0% over the analysis period 2024-2030. ELISA, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$558.3 Million by the end of the analysis period. ... Read More
-
Thyroid Function Tests
... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Lab Automation Equipment and Software
... Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Automated Workstations, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.5 Billion ... Read More
-
D-dimer Testing
... CAGR of 4.0% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end of the ... Read More
-
Hematology Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the analysis period. ... Read More
-
Syphilis Immunoassay Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Point of Care Molecular Diagnostics Market Report by Product and Service (Assays and Kits, Instruments and Analyzers, Software and Services), Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Others), End User (Physicians’ Offices, Hospitals and ICUs, Research Institutes, and Others), and Region 2025-2033
... 8.78% during 2025-2033. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth. Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and ... Read More
-
Microbial Identification Market Report by Products and Services (Instruments and Software, Consumables, Services), Technology (Mass Spectrometry, PCR, Flow Cytometry, Microscopy, and Others), Method (Phenotypic Methods, Genotypic Methods, Proteomics-Based Methods), Application (Diagnostics, Food and Beverage Testing, Pharmaceuticals, Cosmetics and Personal Care Products Testing, and Others), and Region 2025-2033
... There are several factors that are driving the market, which include the increasing focus on food safety testing, expansion of the pharmaceutical and biotechnology industries, and rising need for environmental monitoring in water treatment and ... Read More
Research Assistance
